Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Restructuring Costs (2021 - 2025)

Historic Restructuring Costs for Collegium Pharmaceutical (COLL) over the last 3 years, with Q3 2025 value amounting to $10.9 million.

  • Collegium Pharmaceutical's Restructuring Costs rose 3987.94% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.5 million, marking a year-over-year increase of 5089.39%. This contributed to the annual value of $33.7 million for FY2024, which is 426.95% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Restructuring Costs stood at $10.9 million for Q3 2025, which was up 3987.94% from $9.8 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Restructuring Costs peaked at $13.3 million during Q1 2025, and registered a low of $4.6 million during Q4 2021.
  • Moreover, its 3-year median value for Restructuring Costs was $9.0 million (2024), whereas its average is $9.0 million.
  • The largest annual percentage gain for Collegium Pharmaceutical's Restructuring Costs in the last 5 years was 5411.11% (2025), contrasted with its biggest fall of 2549.3% (2025).
  • Collegium Pharmaceutical's Restructuring Costs (Quarter) stood at $4.6 million in 2021, then surged by 106.92% to $9.5 million in 2024, then increased by 15.12% to $10.9 million in 2025.
  • Its Restructuring Costs was $10.9 million in Q3 2025, compared to $9.8 million in Q2 2025 and $13.3 million in Q1 2025.